Retinal findings in severe malaria appear related to disease

August 09, 2004

CHICAGO - Retinal findings in children with severe forms of malaria (with brain involvement and severe anemia) appear related to disease outcomes such as prolonged coma and death, according to an article in the August issue of The Archives of Ophthalmology, one of the JAMA/Archives journals.

According to the article, severe forms of malaria due to the parasite Plasmodium falciparum, still have high rates of death and disability (including coma) in sub-Saharan Africa, and cause 1.5 to 2.7 million deaths each year, mostly in African children with cerebral malaria (CM) or severe malarial anemia (SMA). Severe malaria is also associated with retinal disorders (retinopathy) which have been found in 77 percent of patients with CM, according to the article.

Nicholas A. Beare, F.R.C.Ophth., of Royal Liverpool University Hospital, England, and colleagues studied 326 children admitted to a central African hospital and treated for CM or SMA during two consecutive malaria seasons. The researchers investigated possible associations between the presence and severity of retinal signs and clinical outcomes in the children.

Of the 326 children, 278 had CM, and of those,170 (61 percent) had retinopathy. Twenty-five of 47 children with SMA had retinopathy. For children with CM, retinopathy was associated with higher death rates, and more severe retinal signs were associated with increasing risk of death and prolonged time to recover consciousness from a comatose state.

"In childhood CM, severity of retinopathy is related to prolonged coma and death," the researchers write. "Our results support the hypothesis that retinal signs in CM are related to cerebral pathophysiology [disease]."

(Arch Ophthalmol. 2004;122:1141-1147. Available post-embargo at Editor's Note: This study was supported by grants from the Beit Trust, Surrey, England; The British Council for Prevention of Blindness, London, England; and The Foundation for the Prevention of Blindness, West Sussex, England. The enrollment and care of the study patients was part of a program funded by The Wellcome Trust, London.
For more information, contact JAMA/Archives Media Relations at 312-464-JAMA (5262) or e-mail

The JAMA Network Journals

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to